A preliminary study:How to protect the oropharynx for patients with nasopharyngeal car-cinoma treated with intensity-modulated radiotherapy

Siming Zheng,Wanqin Cheng,Yong Su,Zheng Wu,Shu Zhou,Jiang Hu,Shaomin Huang
DOI: https://doi.org/10.3969/j.issn.1672-4992.2014.10.14
2014-01-01
Journal of Modern Oncology
Abstract:Objective:To study the relationship between dose volume and acute mucosa reaction of oropharynx of nasopharyngeal carcinoma( NPC)with intensity modulated radiation therapy( IMRT). Methods:All 89 patients with newly diagnosed NPC were into the study diagnosed by pathology and underwent IMRT. Oropharynx and hypopharynx sketch were for organ at risk( OAR). Observe and evaluate the acute mucosa reaction before and after radiotherapy. Results:The average mean dose of oropharynx and hypopharynx was(4743. 1 ± 574. 1)cGy(3469. 5-6121. 7cGy) and(4284. 3 ± 491. 8)cGy(2867. 6-6452. 3cGy),respectively. 0-4 acute oropharynx mucosa reaction rates were 15. 7%,74. 3%,8. 9 %,1. 1%,0%. Oropharynx mucosa reaction during radiotherapy and mean dose,V40 ,V45 ,V50 , V54 were positively correlated(P<0. 01). ROC curve demonstrated that 4890. 2cGy was the best diagnosis critical point of the average dose to oropharynx for acute oropharynx mucositis[ the area under the curve was 0. 869(P<0. 01)]. Conclusion:The patients with radiation-induced oropharyngeal mucositis and oropharyngeal dose volume was significantly related,we suggest that the average dose to oropharyngeal and hypopharyngeal should be limit to 4890cGy and 40-45Gy,and try to reduce the irradiated volume of more than 50Gy. To correct sketch oropharyngeal and hypopharyngeal range,comprehensive oropharyngeal mean dose and dose volume is optimal decision of nasopha-ryngeal carcinoma with IMRT. To reduce the radioactive oropharyngeal and hypopharynx mucositis,improve the quality of life of patients is significant.
What problem does this paper attempt to address?